2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …

IC Van Gelder, M Rienstra, KV Bunting… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary

TF Chao, B Joung, Y Takahashi, TW Lim… - Thrombosis and …, 2022 - thieme-connect.com
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial

S Kar, SK Doshi, A Sadhu, R Horton, J Osorio, C Ellis… - Circulation, 2021 - Am Heart Assoc
Background: Left atrial appendage (LAA) occlusion provides an alternative to oral
anticoagulation for thromboembolic risk reduction in patients with nonvalvular atrial …

Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation

P Osmancik, D Herman, P Neuzil, P Hala… - Journal of the American …, 2020 - jacc.org
Background Percutaneous left atrial appendage closure (LAAC) is noninferior to vitamin K
antagonists (VKAs) for preventing atrial fibrillation (AF)–related stroke. However, direct oral …

4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation

P Osmancik, D Herman, P Neuzil, P Hala… - Journal of the American …, 2022 - jacc.org
Abstract Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel
Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage …

Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation

JV Freeman, AY Higgins, Y Wang, C Du… - Journal of the American …, 2022 - jacc.org
Background Pivotal trials of percutaneous left atrial appendage occlusion (LAAO) used
specific postprocedure treatment protocols. Objectives This study sought to evaluate …

Long-term safety and efficacy in continued access left atrial appendage closure registries

DR Holmes, VY Reddy, NT Gordon, D Delurgio… - Journal of the American …, 2019 - jacc.org
Background: Long-term data on the safety and efficacy of left atrial appendage closure
(LAAC) for stroke prevention in patients with nonvalvular atrial fibrillation remain limited …

Atrial fibrillation and ischemic stroke: a clinical review

I Migdady, A Russman, AB Buletko - Seminars in Neurology, 2021 - thieme-connect.com
Atrial fibrillation (AF) is an important risk factor for ischemic stroke resulting in a fivefold
increased stroke risk and a twofold increased mortality. Our understanding of stroke …

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal

GYH Lip, M Proietti, T Potpara, M Mansour… - Europace, 2023 - academic.oup.com
Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

TF Chao, B Joung, Y Takahashi, TW Lim… - journal of …, 2021 - Wiley Online Library
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …